Probability of EFS (A) and OS (B) for patients undergoing 1 or 2 courses of myeloablative therapy assessed according to landmark analysis (see “Patients and methods”).

Also in this case, selected and unselected transplants were pooled together. Superior EFS is significantly associated with TX2.